Blog
Featured post
Truveta Data leads a new era in cancer research
With more than 7 million oncology patient journeys spanning more than 100 cancer types, Truveta delivers an unprecedented breadth of regulatory grade data to support researchers in accelerating oncology therapy adoption and advancing critical cancer research.
New administrative data in Truveta Data and features in Truveta Studio help researchers accelerate scientifically rigorous research
Today, we're excited to celebrate our latest innovation in Truveta across both Truveta Data and Truveta Studio. Truveta Data has expanded to include new administrative data to...
Beyond trials: How real-world data is transforming autoimmune research
Why autoimmune research needs better real-world data Biologics like Humira, Enbrel, and Rinvoq have transformed autoimmune treatment, revolutionizing treatment for patients with...
GLP-1 RA prescription trends: January 2018 – December 2024
Overall prescribing rates (GLP-1 RA prescriptions per total prescriptions) in December 2024 were similar to September 2024 (+1.89%). Anti-diabetic medication (ADM) prescribing...
Real-world insights on heart failure recovery: A missed opportunity in guideline-directed therapy
Heart failure with reduced ejection fraction (HFrEF) remains a leading cause of morbidity and mortality. While guideline-directed medical therapy (GDMT) has been shown to improve...
Analysis of real-world treatment of epilepsy using Truveta Data
Recently, researchers presented new epilepsy research at the American Epilepsy Society Annual Meeting in Los Angeles, California. Using Truveta Data, the researchers explored two...
Advancing cardiovascular device research with Truveta Data
The need for better cardiovascular device insights Medical device companies are at the forefront of innovation, but a lack of real-world clinical data (RWD) hampers progress in...
Real-time monitoring of respiratory virus-associated hospitalizations: Trends through January 2025
Influenza continues to be on the rise. Influenza-related hospitalizations increased by 53.7% and now are associated with 6.8% of all hospitalizations. For kids aged 4 and younger...
Truveta Data grows to include linked closed claims for more than 200 million patients
Truveta Data has now expanded to include new commercial, Medicare, and Medicaid closed claims on more than 200 million patients, linked with electronic health record (EHR) data...
